Cargando…
Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma
Despite a range of efficacious therapies for asthma, including inhaled corticosteroids (ICS) and long-acting β(2)-agonists (LABA), a significant proportion of patients have poor asthma control and retain a risk of future worsening of their symptoms. Long-acting muscarinic antagonist (LAMA) bronchodi...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500692/ https://www.ncbi.nlm.nih.gov/pubmed/28677351 http://dx.doi.org/10.4168/aair.2017.9.5.386 |